Does predialysis nephrology care influence patient survival after initiation of dialysis?

BACKGROUND Early nephrology referral of patients with chronic kidney disease (CKD) has been suggested to reduce mortality after initiation of dialysis. This retrospective cohort study of incident dialysis patients between 1995 and 1998 was performed to address the association between frequency of nephrology care during the 24 months before initiation of dialysis and first-year mortality after initiation of dialysis. METHODS Patient data were obtained from the Centers for Medicare & Medicaid Services. Patients who started dialysis between 1995 and 1998, and were Medicare-eligible for at least 24 months before initiation of dialysis, were included. One or more nephrology visits during a month was considered a month of nephrology care (MNC). RESULTS Of the total 109,321 patients, only 50% had received nephrology care during the 24 months before initiation of dialysis. Overall, first-year mortality after initiation of dialysis was 36%. Cardiac disease was the major cause of mortality (46%). After adjusting for comorbidity, higher mortality was associated with increasing age (HR, 1.04 per year increase; 95% CI, 1.03 to 1.04) and more frequent visits to generalists (HR, 1.009 per visit increase; 95% CI, 1.003 to 1.014) and specialists (HR, 1.012 per visit increase; 95% CI, 1.011 to 1.013). Compared to patients with >/=3 MNC in the six months before initiation of dialysis, higher mortality was observed among those with no MNC during the 24 months before initiation of dialysis (HR, 1.51; 95% CI, 1.45 to 1.58), no MNC during the six months before initiation of dialysis (HR, 1.28; 95% CI, 1.20 to 1.36), and one or two MNC during the six months before initiation of dialysis (HR, 1.23; 95% CI, 1.18 to 1.29). CONCLUSION Nephrology care before dialysis is important, and consistency of care in the immediate six months before dialysis is a predictor of mortality. Consistent nephrology care may be more important than previously thought, particularly because the frequency and severity of CKD complications increase as patients approach dialysis.

[1]  H. Jacobson,et al.  Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. , 1995, Nihon Jinzo Gakkai shi.

[2]  F. Port,et al.  Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  S. Klahr The modification of diet in renal disease study. , 1989, The New England journal of medicine.

[4]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  A. Collins,et al.  Hematocrit level and associated mortality in hemodialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.

[6]  J. Avorn,et al.  Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. , 2002, Journal of clinical epidemiology.

[7]  W. Owen Status of hemodialysis adequacy in the United States: does it account for improved patient survival? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  M. Saul,et al.  A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. , 2000, The American journal of medicine.

[9]  Giuseppe Remuzzi,et al.  Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria , 1999, The Lancet.

[10]  W. van Biesen,et al.  The pattern of referral of patients with end-stage renal disease to the nephrologist--a European survey. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  P. Roderick,et al.  Late referral for dialysis: improving the management of chronic renal disease. , 2002, QJM : monthly journal of the Association of Physicians.

[12]  W. Keane,et al.  Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  Nancy Fink,et al.  The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality , 2002, Annals of Internal Medicine.

[14]  R. Brant,et al.  Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. , 2001, JAMA.

[15]  B. Kasiske Hyperlipidemia in patients with chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  A. Kausz,et al.  Hospital utilization among chronic dialysis patients. , 2000, Journal of the American Society of Nephrology : JASN.

[17]  R. Sesso,et al.  Late diagnosis of chronic renal failure and mortality on maintenance dialysis , 1996 .

[18]  T. Greene,et al.  Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.

[19]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[20]  G. Shearer,et al.  Mechanisms of hypoalbuminemia in hemodialysis patients (Kidney International 48: (510-516)) , 1995 .

[21]  A. Levin,et al.  Elevated levels of serum creatinine: recommendations for management and referral. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[22]  Z. Massy,et al.  Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  R. Wolfe,et al.  Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. , 2002, Journal of the American Society of Nephrology : JASN.

[24]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[25]  J. Avorn,et al.  Nephrologist care and mortality in patients with chronic renal insufficiency. , 2002, Archives of internal medicine.

[26]  I. Khan,et al.  Chronic renal failure: factors influencing nephrology referral. , 1994, QJM : monthly journal of the Association of Physicians.

[27]  A. Kausz,et al.  Opportunities to improve the care of patients with kidney transplant failure. , 2002, Kidney international.

[28]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[29]  P. Roderick,et al.  Late referral for end-stage renal disease: a region-wide survey in the south west of England. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .

[31]  Ping Wang,et al.  The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases , 1996, Annals of Internal Medicine.

[32]  C. L. Plante 1971 Medicare amendment: reflections on the passage of the end-stage renal disease Medicare program. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  J. Griffith,et al.  Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. , 2002, Journal of the American College of Cardiology.

[34]  M. Fan,et al.  The long-term effects of recombinant human erythropoietin on the cardiovascular system. , 1992, Clinical nephrology.

[35]  Ruth E. Brown,et al.  Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  L. Huiart,et al.  Timing of nephrology referral: influence on mortality and morbidity. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  M. Pfeffer,et al.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  R. Foley,et al.  Anemia as a Risk Factor for Cardiac Disease in Dialysis Patients , 1999 .

[39]  A. Levey Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  K. Iseki,et al.  Serum albumin is a strong predictor of death in chronic dialysis patients. , 1993, Kidney international.

[41]  C. Schmid,et al.  Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease , 2001, Annals of Internal Medicine.

[42]  J. Kopple,et al.  National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[44]  B. Kasiske,et al.  Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.

[45]  J. Domico,et al.  Early referral and its impact on emergent first dialyses, health care costs, and outcome. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  A. Collins,et al.  Hematocrit levels and hospitalization risks in hemodialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.

[47]  David C. Murray,et al.  Outcome and risk factors of ischemic heart disease in chronic uremia. , 1996, Kidney international.

[48]  R. Poveda,et al.  Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[49]  J. Singer,et al.  Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  P. Ratcliffe,et al.  Late referral for maintenance dialysis. , 1984, British medical journal.

[51]  G. Shearer,et al.  Mechanisms of hypoalbuminemia in hemodialysis patients. , 1995, Kidney international.

[52]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  A. Collins,et al.  Trends in anemia at initiation of dialysis in the United States. , 2001, Kidney international.

[54]  David C. Murray,et al.  The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[55]  R. Foley,et al.  Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease and cardiac failure. Semin Dial 2003 , 2022 .

[56]  T. Feest,et al.  Management of anaemia in United Kingdom renal units: a report from the UK Renal Registry. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[57]  A. Collins,et al.  Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  B. Ewigman,et al.  The timing of referral of patients with end-stage renal disease , 1989 .